# Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea

> **NCT00875875** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Travelers' Diarrhea

## Interventions

- **DRUG:** Rifaximin

## Key facts

- **NCT ID:** NCT00875875
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No study population in Mexico (H1N1). Study withdrawn from IRB consideration.
- **Last updated:** 2015-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875875, "Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00875875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*